Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies)
- 1 July 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 74 (1) , 1-4
- https://doi.org/10.1016/0002-9149(94)90481-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarctionThe American Journal of Cardiology, 1988
- Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Controlled comparison with intracoronary streptokinaseJournal of the American College of Cardiology, 1988
- Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionThe American Journal of Cardiology, 1988
- Coronary patency after intravenous infusion of recombinant tissue-type plasminogen activator in acute myocardial infarctionJournal of the American College of Cardiology, 1988
- Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS)Journal of the American College of Cardiology, 1988
- Achievement of Coronary Artery Patency by Use of Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial InfarctionDrugs, 1987
- DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- High dose intravenous streptokinase in acute myocardial infarctionClinical Cardiology, 1983